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background: Obesity is a risk factor for development of atrial fibrillation (AF). The impact on stroke outcomes in patients with AF is unknown. We 
investigated stroke outcomes in normal weight ([NW] BMI 18.50-24.99 kg/m2), overweight ([OW] BMI 25.00-29.99kg/m2), and obese ([OB] BMI 
≥30 kg/m2) patients with AF treated with rivaroxaban and warfarin.
methods: We compared the incidence of stroke and systemic embolic events (SEE) in NW, OW, and OB patients in a post-hoc analysis of the 
ROCKET AF trial.
results: Over 2 years, stroke and SEE rates per 100 patient- years were 3.05 in NW (n=3289), 2.34 in OW (n=5535; HR 0.77, 95% CI 0.62-0.95, 
P=0.013), and 1.90 in OB patients (n=5206; HR 0.62, 95% CI 0.50-0.78, P<0.001). Stroke outcomes for all patients are shown (Figure); similar 
results were observed in rivaroxaban and warfarin groups. OB and OW patients exhibited significantly less risk of stroke than NW patients even after 
adjustment for hypertension, diabetes, CHF, prior stroke/TIA, age, sex, and serum creatinine (OW: HR 0.79, 95% CI 0.64-0.98, P=0.029; OB: HR 0.66, 
95% CI 0.53-0.84, P=<0.001).
conclusion: Obesity may represent an independent predictor of favorable outcome for stroke in patients with AF who are anticoagulated.
 
